<DOC>
	<DOCNO>NCT00321997</DOCNO>
	<brief_summary>The purpose study compare ability different dos pegaptanib sodium safely effectively minimize fluid leakage within eye , thereby stabilize impriving vision patient wet AMD compare placebo injection .</brief_summary>
	<brief_title>A Clinical Trial Explore Safety Efficacy Different Doses Pegaptanib Sodium , Compared Sham , Patients With Wet AMD .</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<criteria>Subjects either gender , age 50 year great . Subfoveal choroidal neovascularization ( CNV ) due AMD . Best correct visual acuity study eye 20/40 20/320 . Any prior subfoveal thermal laser therapy .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2006</verification_date>
	<keyword>AMD</keyword>
	<keyword>Age-Related Macular Degeneration</keyword>
	<keyword>Macular Degeneration</keyword>
	<keyword>Macugen</keyword>
	<keyword>pegaptanib sodium</keyword>
</DOC>